Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

A new study from Karolinska Institutet explores the connection between inflammatory bowel disease (IBD) and chronic kidney ...

We all have them -- or at least one and need the kidney to survive. These vital organs serve as your body's way of getting ...

The administration of President Ferdinand R. Marcos, Jr. has established 126 functional specialty centers across the country, with a total budget allocation amounting to PHP26.3 billion from 2022-2024 ...

Researchers have found in a new study that higher dietary niacin intake was associated with lower all-cause mortality risk in ...

KEY POINTS A 77-year-old man presented to the emergency department with a 4-day history of progressive weakness resulting in recurrent sudden falls at home. He also described fever and cough, ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

Five regions in the U.S. have been selected to implement a new preventive health initiative to improve care for people with a cluster of chronic conditions known as cardiovascular-kidney-metabolic ...

Ben Gurion University researchers identify unique fat cell subpopulations using RNA mapping. Study aids personalised obesity ...